BonTerra Resources Inc V.BTR

Alternate Symbol(s): BONXF

Metals & Mining Gold

Bonterra Resources Inc. is a Canada-based gold exploration company with a portfolio of advanced exploration assets anchored by a central milling facility in Quebec, Canada. The Company is engaged in the business of acquiring, exploring, and evaluating natural resource properties in the province of Quebec. The Company’s assets include Gladiator, Barry, Moroy, and Bachelor. The Company holds a 100% interest in 436 mineral claims covering 22,779.32 hectares surrounding the town of Desmaraisville. The Bachelor Mine is located on one mining concession, and one mining lease, four kilometers (km) south of Highway 113 and 90 km northeast of the city of Lebel-sur-Quevillon. The Company holds a 100% interest in 21 mineral claims in the city of Val-d’Or in Quebec covering 457.53 hectares. The Company holds a 90% interest in two mining leases north of the town of Skead within the city of Greater Sudbury in Ontario. The two mining leases cover an area of approximately 129.99 hectares.

TSXV:BTR - Post by User

BonTerra Resources Inc > Canadian Professor of Viral Immunology University of Guelph

<< Previous

Bullboard Posts

Next >>

Comment by tanninon Jun 04, 2021 7:17pm

51 Views

Post# 33334917

RE:Canadian Professor of Viral Immunology University of Guelph

@glenpyle

May 28

3. Spike protein gets in the blood. In small amounts yes. Concentration around 0.3 pM. Kd of ACE2 binding is ~1.5 nM. This means the concentration in blood is 5-fold less than needed to bind ACE2. And that doesn't even consider engineering to limit binding.

Iluv, seems like may not be a problem at all.....however, thx for the info...had no idea about any of this. Would also mention that this does not refer to the astrazeneca vaccine.

<< Previous

Bullboard Posts

Next >>

Cameco raises uranium output as Q3 results surge